BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesBrandPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsCAR-T Cell Therapy Services: Yescarta and Tecartus
    Awarded contract

    CAR-T Cell Therapy Services: Yescarta and Tecartus

    Awarded
    £894k
    Published 19 Oct 2026

    Procurement for supply and administration services of CAR-T cell therapies Yescarta and Tecartus for cancer treatment.

    🇬🇧United Kingdom· North WestPublished 19 Oct 2026· YesterdayviaFind a Tender
    Awarded
    £894k
    Published 19 Oct 2026

    Decision brief

    4 fields
    • Contract value
      £893,953
      Pounds sterling
    • Closing date
      Not published
      No closing date published
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇬🇧United Kingdom
      North West

    Suppliers

    1 supplier
    • GS
      Gilead Sciences Ltd
    Lead contractor

    Lifecycle

    Awarded

    Contract awarded. Originally published yesterday.

    19 October 2026
    Awarded — no open tender advertised

    Brief

    This opportunity seeks qualified providers to supply and administer CAR-T cell therapy treatments, specifically Yescarta (axicabtagene ciloleucel) and Tecartus (brexucabtagene autoleucel). These advanced immunotherapies are used to treat certain blood cancers by genetically modifying a patient's own T cells to recognize and destroy cancer cells. Qualified suppliers should have expertise in cell therapy manufacturing, cryopreservation, logistics, clinical administration, and patient management. Vendors must comply with all FDA regulations, maintain appropriate certifications, and demonstrate experience with complex biologic therapies.

    Track record

    3 awards · 2 winners
    Open field

    No single supplier dominates the field.

    In healthcare medical, The Clatterbridge Cancer Centre NHS Foundation Trust has awarded 3 contracts to 2 suppliers.

    Who wins here
    1. BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED2× · 67%
    2. Gilead Sciences Ltd1× · 33%

    Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.

    More from The Clatterbridge Cancer Centre NHS Foundation Trust

    4 listingsView all →
    OpenHealthcare & Medical🇬🇧United Kingdom

    Radiopharmaceuticals Service for Cancer Diagnostics and Therapy

    Clatterbridge Cancer Centre NHS Foundation Trust seeks a comprehensive radiopharmaceuticals service provider for cancer diagnostics and therapy, including cyclotron-based radiopharmacy and multiple radiopharmaceutical production capabilities.

    The Clatterbridge Cancer Centre NHS Foundation Trust
    Published 20 Oct 2026
    AwardedHealthcare & Medical🇬🇧United Kingdom

    Supply of Breyanzi CAR-T Cell Therapy Products

    NHS England is procuring Breyanzi CAR-T cell therapy products for direct supply to the National Health Service.

    £140,250The Clatterbridge Cancer Centre NHS Foundation Trust
    Published 8 Oct 2026
    AwardedEngineering🇬🇧United Kingdom

    Building Management System for Clatterbridge Cancer Centre

    Clatterbridge Cancer Centre seeks a Building Management System provider to integrate facility controls and monitoring across its Aintree location.

    £108,923The Clatterbridge Cancer Centre NHS Foundation Trust
    Published 7 Oct 2026
    AwardedIT & Software🇬🇧United Kingdom

    RayStation Software Maintenance and Support Service – Year 4

    Opportunity to provide Year 4 maintenance and technical support services for RayStation software platform.

    £58,692The Clatterbridge Cancer Centre NHS Foundation Trust
    Published 2 Oct 2026

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇬🇧United Kingdom

    Medical Countermeasures for Chemical, Biological, Radiological and Nuclear (CBRN) Threats - R&D Funding

    Develop medical countermeasures for CBRN threats with up to £4 million funding over 30 months, from prototype through Phase 2a clinical studies.

    est.£4,000,000
    Published 5 Nov 2026
    Healthcare & Medical🇬🇧United Kingdom

    Clinical Research Training Fellowship for Healthcare Professionals

    A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.

    Medical Research Council (MRC)
    Published 21 Oct 2026
    Healthcare & Medical🇬🇧United Kingdom

    Slit-Lamp Simulator with Components and Software

    Procurement of a slit-lamp simulator system with all components and software for ophthalmology training and education.

    The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
    Published 20 Oct 2026
    Healthcare & Medical🇬🇧United Kingdom

    Epistaxis Treatment Device

    Seeking consumable medical devices for treating epistaxis (nosebleeds) in clinical and emergency settings.

    est.£3,563The Shrewsbury and Telford Hospital NHS Trust
    Published 20 Oct 2026
    Take action
    View on sourceFind a Tender

    Award notice and full record on the publisher's site

    Publisher
    UK Cabinet Office
    Licence
    OGL v3.0
    Source
    find-tender.service.gov.uk
    Record ID
    ocds-h6vhtk-078abb

    Your fit

    Could you win the next one?

    This went to Gilead Sciences Ltd. Sonar reads The Clatterbridge Cancer Centre NHS Foundation Trust's work like this against your business — who holds it, and whether you could compete or partner next time.

    Check my fit

    Free · Matches every Monday

    CC
    Buyer
    The Clatterbridge Cancer Centre NHS Foundation Trust
    Sector
    Healthcare & Medical